Solid Biosciences Inc.

A life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases.

Drug Discovery
Active
Charlestown, United States Founded 2013
Website ↗
Last updated 2026-08-21
Total raised
Stage
Founded
2013
Headcount
HQ
Charlestown, United States
Sector
Drug Discovery

About

Solid Biosciences Inc. is a life sciences company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (DMD), Friedreich's ataxia (FA), and catecholaminergic polymorphic ventricular tachycardia (CPVT). The company aims to develop innovative libraries of genetic regulators and other enabling technologies to impact gene therapy delivery. Solid Biosciences was founded by individuals directly impacted by Duchenne muscular dystrophy, and its mission is to improve the daily lives of patients living with devastating rare diseases.

Funding history · 1 round · — total

2013
Seed Undisclosed

Q&A

What is Solid Biosciences Inc.'s primary focus?
Solid Biosciences Inc. is a life sciences company dedicated to developing precision genetic medicines for rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (DMD), Friedreich's ataxia (FA), and catecholaminergic polymorphic ventricular tachycardia (CPVT).
When was Solid Biosciences Inc. founded?
Solid Biosciences Inc. was founded in 2013.
Who is the current President and CEO of Solid Biosciences Inc.?
Bo Cumbo was appointed President and CEO of Solid Biosciences Inc. in December 2022.
What is Solid Biosciences Inc.'s mission?
Solid Biosciences Inc.'s mission is to improve the daily lives of patients living with devastating rare diseases, driven by its founders who were directly impacted by Duchenne muscular dystrophy.
What types of diseases does Solid Biosciences Inc. target with its gene therapy candidates?
Solid Biosciences Inc. targets rare neuromuscular and cardiac diseases such as Duchenne muscular dystrophy, Friedreich's ataxia, catecholaminergic polymorphic ventricular tachycardia, and TNNT2-mediated dilated cardiomyopathy.
Where is Solid Biosciences Inc. headquartered?
Solid Biosciences Inc. is headquartered in Charlestown, United States.

Team · 2

Ilan Ganot
Founder · Co-founder and Director
Bo Cumbo
President and CEO

Sectors & technology

Primary sector
Drug Discovery
Technologies
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesolidbio.com

Identifiers & details

Legal nameSolid Biosciences Inc.
Founded2013